Eye Scan Test App To Detect COVID-19 Soon To Be Launched By German Firm

Updated: Aug 20

A German-based tech company recently created an app that can detect COVID-19 infection with just an eye scan.

semic rf eye scan

Credit: Semic RF

SEMIC EyeScan, an app developed by SEMIC RF, works by using a patented artificial intelligence (AI) to look for a specific shade of pink in a person’s eye and deliver results in just three to five minutes. The purely non-invasive test only needs a picture of either or both eyes, a smartphone with at least a 12-megapixel camera and a stable Wi-Fi connection. SEMIC guarantees an analytical sensitivity/specificity of 97% when using this test method.


The company mentioned that it combined its experience from its past endeavour, the Cradle project, and findings from its test involving 450 COVID-19 infected individuals in 2020 to identify the specific shade of pink associated with COVID-19 infection from over two million different shades. SEMIC was able to develop the EyeScan further after evaluating 70,000 patient data when they added YUV colour model technology and integrated the gamma compression method.


Wolfgang Gruber, SEMIC RF’s Managing Director, expected that the app can process a million scans per second and has the capability to expand the capacity further, according to a Reuters report. He also added that the app could potentially allow crowds back into mass-attendance events like concerts and football matches.

federal institute for drugs and medical devices germany

The Federal Institute for Drugs and Medical Devices in Bonn, Germany Credit: BfArM/Frank Ruemmele

Reuters also mentioned that Gruber is hoping to release the app by the end of May 2021. Meanwhile, SEMIC is currently waiting for approval from the German BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte), Germany’s medical device regulatory authority, to market the app in the European Union and is also awaiting regulatory approval from the United States.


The SEMIC EyeScan app was also found to be able to detect the presence of alcohol, drugs, nicotine and other diseases which are:

  • Bile disorders

  • Diabetes

  • Floater

  • Hepatitis

  • Influenza

  • Leaky gut

  • Liver disease

  • Lung disease

  • Stomach tumours

  • Spondylitis

  • Typhus

  • Uterine fibroids

It is reported that the app is initially being targeted for release to companies and commercial users for €480 a month while a later release is being planned for public with no mention if it will be free for downloads.

Written by John Paul Joaquin

LG side